Cargando…
Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study
Prader–Willi Syndrome (PWS) is a rare genetic syndrome leading to severe behavioural disorders and mild cognitive impairment. The objective of this double-blind randomised placebo-controlled trial was to study the efficacy and tolerance of topiramate on behavioural disorders in patients with PWS. Pa...
Autores principales: | Consoli, Angèle, Çabal Berthoumieu, Sophie, Raffin, Marie, Thuilleaux, Denise, Poitou, Christine, Coupaye, Muriel, Pinto, Graziella, Lebbah, Said, Zahr, Noel, Tauber, Maïthé, Cohen, David, Bonnot, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828670/ https://www.ncbi.nlm.nih.gov/pubmed/31685813 http://dx.doi.org/10.1038/s41398-019-0597-0 |
Ejemplares similares
-
Prader–Willi syndrome: Symptoms and topiramate response in light of genetics
por: Louveau, Cécile, et al.
Publicado: (2023) -
Corrigendum: Prader-Willi syndrome: Symptoms and topiramate response in light of genetics
por: Louveau, Cécile, et al.
Publicado: (2023) -
Causes of death in Prader-Willi syndrome: lessons from 11 years’ experience of a national reference center
por: Pacoricona Alfaro, Dibia Liz, et al.
Publicado: (2019) -
Physical Activity in Patients with Prader-Willi Syndrome—A Systematic Review of Observational and Interventional Studies
por: Bellicha, Alice, et al.
Publicado: (2021) -
Effects of the COVID-19 pandemic and lockdown on the mental and physical health of adults with Prader-Willi syndrome
por: Mosbah, Helena, et al.
Publicado: (2021)